Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$23,061,491
+$9,360,141 QoQ
Shares Held
90,804
+62.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#681
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banque Cantonale Vaudoise holds $123,482,590 across 10 Drug Manufacturers - General names. JNJ ranks #2 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,866 | $26,226,738 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
90,804 | $23,061,491 | |
| 3 | ABBV |
AbbVie Inc.
|
89,306 | $22,472,961 | |
| 4 | MRK |
Merck & Co., Inc.
|
105,147 | $13,511,389 | |
| 5 | AZN |
Astrazeneca PLC
|
60,462 | $11,464,804 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
63,781 | $8,058,091 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
136,299 | $7,853,548 | |
| 8 | PFE |
Pfizer Inc
|
286,435 | $6,897,354 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,061,491 | 90,804 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $13,701,350 | 56,052 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $11,751,655 | 56,785 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $13,218,591 | 71,290 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,694,791 | 70,015 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $13,475,163 | 81,254 | Shares | Sole | 2025-05-08 | |
| 2024-09-30 | $10,313,984 | 63,643 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $11,711,654 | 80,129 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $12,750,114 | 80,600 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $15,643,435 | 99,805 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $15,467,999 | 99,313 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $33,470,791 | 202,216 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $27,031,535 | 174,397 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $30,275,690 | 171,388 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $26,302,920 | 161,012 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $16,687,892 | 94,011 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $19,989,240 | 112,787 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $19,604,279 | 114,598 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $16,699,907 | 103,405 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $16,238,421 | 98,570 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $16,056,995 | 97,700 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $15,710,773 | 99,827 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $17,240,304 | 115,800 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $15,297,028 | 108,775 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $11,175,554 | 85,225 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||